Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease... Show more
a company, which engages in the development of an immune medicine platform
Industry MedicalSpecialties
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ISHP | 36.87 | 0.56 | +1.54% |
| First Trust S-Network Glb E-Com ETF | |||
| NDMO | 10.02 | 0.09 | +0.91% |
| Nuveen Dynamic Municipal Opportunities Fund | |||
| SPMB | 22.03 | 0.07 | +0.32% |
| State Street SPDR Port Mortg Bckd Bd ETF | |||
| MYCJ | 24.49 | 0.04 | +0.18% |
| State Street® My2030 Corporate Bond ETF | |||
| TOLZ | 58.96 | -0.15 | -0.26% |
| ProShares DJ Brookfield Global Infras | |||
A.I.dvisor indicates that over the last year, ADPT has been loosely correlated with AXON. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ADPT jumps, then AXON could also see price increases.
| Ticker / NAME | Correlation To ADPT | 1D Price Change % | ||
|---|---|---|---|---|
| ADPT | 100% | +5.64% | ||
| AXON - ADPT | 56% Loosely correlated | +9.29% | ||
| VCYT - ADPT | 53% Loosely correlated | +2.32% | ||
| PSNL - ADPT | 51% Loosely correlated | +8.67% | ||
| ARRY - ADPT | 50% Loosely correlated | +5.71% | ||
| NTRA - ADPT | 49% Loosely correlated | +21.37% | ||
More | ||||
| Ticker / NAME | Correlation To ADPT | 1D Price Change % |
|---|---|---|
| ADPT | 100% | +5.64% |
| Medical Specialties category (45 stocks) | 56% Loosely correlated | +2.67% |
| Medical Specialties category (45 stocks) | 56% Loosely correlated | +2.67% |
ADPT saw its Momentum Indicator move above the 0 level on August 03, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned positive. In of the 87 cases, the stock moved higher in the following days. The odds of a move higher are at .
The Moving Average Convergence Divergence (MACD) for ADPT just turned positive on August 07, 2026. Looking at past instances where ADPT's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .
The 50-day moving average for ADPT moved above the 200-day moving average on July 01, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ADPT advanced for three days, in of 282 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 160 cases where ADPT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for ADPT moved out of overbought territory on July 31, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADPT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
ADPT broke above its upper Bollinger Band on August 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ADPT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (27.778) is normal, around the industry mean (69.030). P/E Ratio (0.000) is within average values for comparable stocks, (154.745). ADPT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.671). ADPT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.007). P/S Ratio (12.563) is also within normal values, averaging (9.093).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ADPT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.